Mexiletine
مگزیلتین
❤️ Cardiovascular SystemClass IB antiarrhythmic
Market / country: 🇺🇸 USA
Mexiletine (US)
🧮 Dose calculator
Life-threatening ventricular arrhythmia · Regimen source: FDA Mexiletine · Dosage and Administration
- • Most are controlled by 200–300 mg every 8 h; adjust by 50 or 100 mg every 2–3 days. Rapid control: 400 mg loading then 200 mg 8 h later. ECG and Holter monitoring. FDA Mexiletine · Dosage and Administration
Enter age (weight is optional for this regimen).
🛡️ Safety & information
Contraindications
- ⛔ Cardiogenic shock; second- or third-degree AV block without a pacemaker. FDA Mexiletine · Contraindications
Warnings
- • Boxed warning: increased mortality with class I antiarrhythmics after MI (CAST) — reserve for life-threatening ventricular arrhythmia. FDA Mexiletine · Boxed Warning
Formulations
- 200 mg capsule — capsule 🇺🇸 USA FDA Mexiletine · How Supplied
- 150 mg capsule — capsule 🇺🇸 USA FDA Mexiletine · How Supplied
- 250 mg capsule — capsule 🇺🇸 USA FDA Mexiletine · How Supplied
👥 Special populations
- 🤰 PregnancyUse with caution
Label states no clear risk or has limited data; use only if needed, under medical advice. FDA Mexiletine · Precautions/Warnings – Pregnancy
“Teratogenic Effects Reproduction studies performed with mexiletine in rats, mice and rabbits at doses up to four times the maximum human oral dose (24 mg/kg in a 50 kg patient) revealed no evidence of teratogenicity or impaired fertility but did show an increase in fetal resorption.”
- 🤱 BreastfeedingUse with caution
Label: use with caution while breastfeeding; see the label text. FDA Mexiletine · Precautions/Warnings – Nursing Mothers
“Mexiletine appears in human milk in concentrations similar to those observed in plasma.”
- 👶 ChildrenSafety not established
Label: safety and effectiveness in children have not been established. FDA Mexiletine · Precautions/Warnings – Pediatric Use
“Safety and effectiveness in pediatric patients have not been established.”
- 👴 Older adultsNo data
The source for this drug has no section for this group.
- ⚥ Females & males of reproductive potentialNo data
The source for this drug has no section for this group.
🔗 Reference links
- FDA (approval record)ANDA214089
- DailyMed (FDA label)FDA Mexiletine
- MedlinePlus (NIH)Mexiletine
- WHO ATC/DDDC01BB02
- Darooyab (Iran)Mexiletine
🇮🇷 Registered in Iran Darooyab · G-1769/Mexiletine
Dosage forms with Iranian generic codes, per Darooyab.
- 00848 · MEXILETINE HCL 100MG CAP · کپسول مکزیلتین هیدروکلراید ۱۰۰ میلیگرم
- 14557 · MEXILETINE HCL 100MG TAB · قرص مکزیلتین هیدروکلراید ۱۰۰ میلیگرم
- 00849 · MEXILETINE HCL 200MG CAP · کپسول مکزیلتین هیدروکلراید ۲۰۰ میلیگرم
- 17782 · MEXILETINE HCL 200MG TAB · قرص مکزیلتین هیدروکلراید ۲۰۰ میلیگرم
- 09574 · MEXILETINE HCL 50MG TAB · قرص مکزیلتین هیدروکلراید ۵۰ میلیگرم
📚 Reference status for this drug
Shows which sources have references recorded for this drug and which do not.
- FDA label (DailyMed)✅ PresentFDA Mexiletine · How SuppliedFDA Mexiletine · Dosage and AdministrationFDA Mexiletine · ContraindicationsFDA Mexiletine · Boxed WarningFDA Mexiletine · SPL approval / marketing categoryFDA Mexiletine · Precautions/Warnings – PregnancyFDA Mexiletine · Precautions/Warnings – Nursing MothersFDA Mexiletine · Precautions/Warnings – Pediatric Use
- UK SmPC (eMC / MHRA)❌ Not present
- Published guideline❌ Not present
- Licensed reference (medical school)❌ Not present
- Iranian leaflet (IFDA)❌ Not present
- Pharmacy website (secondary, unreliable)✅ PresentDarooyab · G-1769/Mexiletine
- Clinical review⚠ Unverified